Buagafuran

布格呋喃

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameBuagafuran
Drug Alias NameAF-5AF-05
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAnxiety DisordersAnxietyDrug-Related Side Effects and Adverse Reactions
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsAnxiety DisordersDrug-Related Side Effects and Adverse Reactions
Inactive IndicationsAnxiety

Other Information

ATC CodeN/A
Related LinksN/A